Rapid target engagement of KRAS G12C tricomplex inhibitor RO3903 overcomes resistance and drives durable tumor regression. (pnas.org)

Authors: Yao X … Yang B Journal: PNAS Published: 2026-11-03 DOI: https://doi.org/10.1073/pnas.2621263123